Breast Cancer Clinical Trials

Showing 5441-5460 of 5,597 trials

Yunzhi as Dietary Supplement in Breast Cancer

NCT00647075

The purpose of this study is to assess the effects of a dietary supplement, the traditional Asian mushroom Yunzhi, as adjuvant in the treatment of patients with breast cancer.

Breast Cancer

Hospital Clinic of Barcelona60 participantsStarted Nov 2007

Barcelona, Barcelona, Spain • Sabadell, Barcelona, Spain

COMPLETEDPhase 3

Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer

NCT00078572

This study was designed to compare the efficacy and safety of an oral dual tyrosine kinase inhibitor in combination with capecitabine versus capecitabine alone in women with locally advanced or metastatic breast cancer that has not responded to previous therapy.

Breast Cancer

GlaxoSmithKline408 participantsStarted Mar 2004

COMPLETED

National Survey on Infiltrative Breast Cancer

NCT00696527

The purpose of this observational study is to describe radiological, clinical and histological characteristics of women with infiltrative breast cancer.

Infiltrative Breast Cancer

AstraZeneca1,500 participantsStarted Jun 2007

Aix-en-Provence, France • Alès, France • Amilly, France +104 more locations

Yunzhi as Dietary Supplement in Breast Cancer

Capecitabine (XELODA) With Or Without Lapatinib (GW572016) For Women With Refractory Advanced or Metastatic Breast Cancer

National Survey on Infiltrative Breast Cancer

Related Searches

Expanding Rural Access: Distance Delivery of Support Groups (Main Study)

Faslodex 500mg Multiple Dose Tolerability Study in BC Patients

Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

Efficacy and Safety Study of Neoadjuvant Chemotherapy for Local Advanced Triple Negative Breast Cancer Patients

Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer

Effect of Bazedoxifene, Raloxifene, and Placebo on Breast Density

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Metabolic Syndrome as Modifiable Risk Factor for Breast Cancer

Adjuvant Treatment of Breast Cancer With 1-3 Aflicted Lymph Nodes

Efficacy and Safety of Clino-san on Vaginal Dryness of Breast Cancer Patients

Lymphatic Mapping After Previous Breast Surgery

10 Year Coronary Heart Disease (CHD) Risk Evaluation and Its Treatment Pattern Analysis in Postmenopausal Early Breast Cancer (EBC) Patients Taking Aromatase Inhibitors (AI)

Manual Therapy in Postoperative Breast Cancer

SU5416 and Doxorubicin in Treating Patients With Stage IIIB or Stage IV Inflammatory Breast Cancer

Vaccination of Metastatic Breast Cancer Patients With a CD80-modified Allogeneic Cancer Cell Line (KS2422)